32 The primary outcome for the trial was the first occurrence of a major adverse cardiovascular event (death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke)
This support piece is a big part of the program
Nutritional deficiencies may develop during GLP-1 treatment, particularly when appetite suppression leads to inadequate dietary intake
Since its inception, Now Foods has been dedicated to producing healthy and nutritious food, a commitment that continues to this day
Each weekly dose should be carefully documented, stored at proper temperature, and disposed of following biosafety standards
Products are supplied strictly as reference materials for in-vitro laboratory research by qualified professionals